In order to compare the standard swim-up semen preparation with and without test yolk buffer (TYB) incubation in intrauterine insemination (IUI), we conducted a prospective multicentre randomized trial. A total of 121 infertile couples with male factor (n ⍧ 52) or unexplained infertility (n ϭ 69) was randomly assigned to two groups following ovulation induction. Semen was prepared by standard swim-up in group A (n ⍧ 64) and by swim-up followed by TYB incubation in group B (n ⍧ 57). A maximum of two IUI cycles was performed. A total of 104 cycles was performed in the swim-up group and 90 in the TYB group. Overall, 15 pregnancies were achieved in group A and 23 in group B, with an overall pregnancy rate of 24.8 and 50.0% per patient respectively (χ 2 1 , P < 0.05). In the male factor group, pregnancy was achieved in six out of 24 couples (25%) following standard swim-up and in six out of 28 (21.4%) following swim-up and TYB incubation (χ 2 1 , not significant). In the unexplained infertility group, pregnancy was recorded in nine out of 40 couples (22.5%) following standard swim-up and in 17 out of 29 couples (58.6%) following swim-up and TYB incubation (χ 2 1 , P < 0.05).
Introduction
Intrauterine insemination (IUI) is one of the most widely used assisted reproductive techniques in patients with moderate male factor or unexplained infertility as a first step before undergoing more expensive and complex programmes such as in-vitro fertilization (IVF) (Dodson and Haney, 1991) .
Several attempts have been made to improve success rate in IUI by means of superovulation (Gallot-Lavallee et al., 1995) or double insemination (Silverberg et al., 1992; Ransom et al., 1994) . However, very few studies have investigated whether semen preparation techniques may improve fertilization rates (Blumenfeld and Nahhas, 1989; Rogers, 1990a; Menge et al., 1992) .
Semen incubation using prepared media with egg yolk and two buffers, TES [N-tris(hydroxymethyl)methyl-2-aminoethane sulphonic acid] and Tris, known as test yolk buffer (TYB) has been reported to improve sperm penetration (Biefeld et al., 1990) . Some authors have reported a higher fertilization rate with TYB semen incubation in IVF-embryo transfer programmes (Katayama et al., 1989; Paulson et al., 1992) while other authors have reported no significant differences with or without TYB (Rogers, 1990b; Quinn et al., 1992) . Very few studies have investigated the therapeutic effect of TYB in IUI.
The aim of the present study was to compare spermatozoa prepared by standard swim-up methods versus swim-up followed by TYB incubation during IUI. The study was conducted according to a prospective, randomized, multicentre design.
Materials and methods

Patient population
The Infertility Units of the University of Milan, Modena and Florence enrolled a total of 146 couples. Laboratory methods and clinical treatments among couples in the three centres were performed according to a centralized protocol. Couples were diagnosed with having male factor or unexplained infertility for a period of at least 3 years prior to study entry.
Male factor inclusion criteria
The inclusion criteria for male factor infertility patients were: (i) male patients with complete medical history, physical and endocrinological examination; (ii) at least two abnormal semen analyses (World Health Organization criteria, WHO, 1992); (iii) diagnosis confirmed by additional semen analysis 1 month prior to insemination, with a sperm recovery of Ͼ1.5ϫ10 6 /ml after swim-up (Byrd et al., 1990) ; and (iv) female patients with normal prolactin levels and 24-32 day ovulatory cycles, with mid-luteal phase serum progesterone concentrations Ͼ10 ng/ml, normal uterine cavity and bilateral tubal patency, confirmed by hysterosalpingography or by hysteroscopy and laparoscopy with chromosalpinography performed within 2 years prior to study inclusion.
Unexplained infertility inclusion criteria
These included: (i) male patients with at least two normal semen analyses; (ii) normal complete medical history, physical and endocrinological examination for both partners; (iii) female patients with normal prolactin concentrations and 24-32 day ovulatory cycles, with mid-luteal phase serum progesterone concentrations Ͼ10 ng/ml; and (iv) normal uterine cavity and bilateral tubal patency, confirmed by hysterosalpingography or by hysteroscopy and laparoscopy with chromosalpinography performed within 2 years prior to study inclusion. A post-coital test was not performed.
Male factor and unexplained infertility exclusion criteria These were: (i) women Ͼ38 years old; (ii) women showing ovarian cysts ജ3 cm at transvaginal ultrasonography at the beginning of ovarian stimulation; (iii) women with polycystic ovarian syndrome; (iv) women with body mass index Ͼ25; and (v) patients with more than six follicles with a mean diameter of Ͼ18 mm on the day of ovulatory trigger due to increased risk of multiple pregnancy.
Patients were randomized into two groups on the day of ovulatory trigger. In group A (n ϭ 76) semen was prepared by standard swimup and in group B (n ϭ 70), semen was prepared by swim-up followed by TYB incubation. A maximum of two IUI cycles were performed in both groups. Severe semen abnormalities on the day of the first cycle insemination (recovery Ͻ1.5ϫ10 6 /ml of motile spermatozoa) were found in 12 men with male factor randomized to group A and in 13 men with male factor randomized to group B. These couples were withdrawn from the study and were not included in this analysis.
Randomization was centrally performed by telephone using a computer generated list. The study was approved by the local Ethics Committee in accordance with the 1975 Helsinki Declaration on human experimentation and all couples gave written informed consent.
Ovulation induction
All female patients received clomiphene citrate (100 mg/day from days 3-7 of the cycle, Clomid; Lepetit, Italy) combined with pure follicle-stimulating hormone (Metrodin 75 IU; Serono, Italy), two ampoules per day from cycle day 6. Follicular growth was measured on alternate days starting from cycle day 8 with transvaginal ultrasonography.
Patients were administered 5000 IU of human chorionic gonadotrophin (HCG, Profasi 5000 IU; Serono) as an ovulatory trigger when the leading follicle reached a diameter of 18-20 mm. The protocol indicated that HCG was not given in cases where there were Ͼ6 follicles in both ovaries. Luteal supplementation was not performed. No cases of ovarian hyperstimulation syndrome were observed.
Semen preparation and insemination
Semen samples were collected according to standard procedures (WHO, 1992) . Samples were allowed to liquefy for 30 min at room temperature. The entire semen volume of samples collected from patients with male factor and the entire volume, or an aliquot in the case of very good samples, collected from patients with unexplained infertility, were treated. The direct swim-up technique was used to treat semen samples collected from group A. Semen samples (1 ml aliquots) were layered under 1 ml of Earle's medium and incubated for 30 min at 37°C in 5% CO 2 . The upper interface was then gently aspirated with a Pasteur pipette and washed in 4 ml of medium by centrifugation at 200 g for 10 min. The pellet was then diluted to 0.5 ml.
In group B, after swim-up and centrifugation, the pellet was suspended with room temperature medium and diluted dropwise with room temperature TYB (Irvine Scientific, CA, USA) to a 1:1 dilution. The TYB specimen was then placed in a room temperature water bath and incubated in a refrigerator at 4°C for 2 h. TYB was removed by two washings with 4 and 2 ml of room temperature medium and centrifuged at 200 g for 5 min. The pellet was then diluted to 0.5 ml and incubated at 37°C in 5% CO 2 .
Insemination was performed once,~34 h after ovulatory triggering by slowly injecting 0.5 ml of prepared semen into the uterine cavity with a Kremer Delafontaine catheter (Laboratoire CCD, Neuilly-en- Thelle, France). Pregnancy was confirmed by evidence of fetal heart activity at ultrasound.
Statistical analysis
Baseline homogeneity between treatment groups was statistically analysed using Student's t-test and χ 2 test. The two-cycle cumulative pregnancy rates were calculated by life-table analysis using the actuarial method and the difference tested by the log rank test (Peto et al., 1977) . Differences in pregnancy and birth rates between treatment groups were analysed using the χ 2 test and the potential confounding effect of age (ഛ35, Ͼ35 years) and the cause of infertility (male factor, unexplained infertility) were taken into account using the MantelHaenszel procedure (Mantel and Haenszel, 1959) .
Furthermore, in order to take into account the potential confounding effects of other factors, we conducted a multiple logistic regression analysis with pregnancy as a dependent variable and group as an independent one, adjusted for age (ഛ35; Ͼ35 years), indication (male factor, unexplained infertility), sperm concentration (ഛ20ϫ10 6 /ml; Ͼ20ϫ10 6 /ml), sperm values at first cycle (Ͻ2 ml; ജ2 ml), progressive motility at first cycle (Ͻ25%; Ͼ25%) and number of follicles Ͼ15 mm at first cycle (ഛ2; Ͼ2). Tables I and II. A total of 62.5% of patients in the standard swim-up group and 50.9% in the TYB group had a diagnosis of unexplained infertility. The difference was not statistically significant with the exception of the percentage progressive motility before the second cycle which was higher in group A than in group B.
Results
Patient and semen characteristics by treatment group are given in
Overall, 194 cycles were performed in the two groups, 104 (64 first and 40 second cycles) in the standard swim-up group and 90 (57 first cycles and 33 second cycles) in the TYB group. Table III shows the pregnancy and birth rates by treatment group and by cause of infertility.
A total of 48 couples dropped out before the second cycle due to severe abnormal semen on the day of insemination, with a recovery of Ͻ1.5 ϫ10 6 /ml of motile spermatozoa or due to withdrawal of consent (24 couples in each of the swimup and TYB groups). A total of 15 pregnancies occurred in group A and 23 in group B (Table III) , with an overall pregnancy rate of 23.4 and 40.4% per patient respectively (χ 2 a Parameter estimated from a multiple logistic regression with pregnancy as a dependent variable and group as an independent varaiable, adjusted for age (ഛ35, Ͼ35 years), indication, volume (Ͻ2, Ͼ2 ml), concentration and progressive motility (ഛ25%, Ͼ25%). β pool of first cycle, plus two more ϭ 0.76 (P ϭ 0.05). NS ϭ not significant.
adjusted for age and indication, P Ͻ 0.05), and 14.4 and 25.5% per cycle (χ 2 1 adjusted for age and indication, not significant). The parameter estimated from a multiple logistic regression analysis with pregnancy as a dependent variable and treatment group as an independent one, adjusted for potential covariates was 0.76 (P ϭ 0.05). The overall twocycle cumulative pregnancy rates per patient were 24.8 and 50.0% respectively.
Out of the patients with male factor, pregnancy was achieved in six out of 24 (25%) in the standard swim-up group and in six out of 28 (21.4%) in the TYB group (χ 2 1 adjusted for age, not significant). Of patients with unexplained infertility, pregnancy was recorded in nine out of 40 couples in the standard swim-up group and in 17 out of 29 couples in the TYB group (χ 2 1 adjusted for age, P Ͻ 0.05). There were four multiple pregnancies (twins): two in the swim-up and two in the TYB group.
A total of 10 births out of 15 pregnancies (66.7%) in the swim-up group and 16 births out of 23 pregnancies (69.6%) in the TYB group were recorded (Fisher's exact test; not significant). No extrauterine pregnancies, intrauterine or perinatal deaths were observed.
Discussion
Although the advantages of TYB in semen cryopreservation have been reported in numerous studies over the past 10 years (Jeyendran et al., 1995) , very few controlled trials have been performed to assess its potential therapeutic clinical effects. In this study, we evaluated the effectiveness of spermatozoa prepared by swim-up followed by TYB incubation in couples with male factor or unexplained infertility taking part in an IUI programme.
Potential limitations of this study should be considered. First of all we have chosen to define male infertility using the criteria proposed by WHO (1992) , which can be considered mild criteria. Thus, in the population studied here, there was no clear border between unexplained infertility and male subfertility.
Furthermore, the mean age of the patients was 32 years, suggesting a favourable reproductive prognosis. However, we have included only women with a history of infertility lasting 3 years or more.
With regard to baseline characteristics of the study groups, it should be underlined that the two groups were similar with regard to age, cause of infertility, ovulation induction and semen characteristics.
Our results show that TYB significantly increased the pregnancy rate compared with spermatozoa prepared by standard swim-up, and are in agreement with results obtained by other authors. Rogers et al. (1990a) performed a large but not randomized study which compared TYB and BWW medium in 1181 intrauterine inseminations. This study showed that TYB improved the pregnancy rate. Menge et al. (1992) carried out a prospective randomized study in 108 patients with male factor or unexplained infertility undergoing an IUI programme. They found that TYB improved the pregnancy rate after the first cycle in couples with unexplained infertility, but not in those with male factor infertility.
The mechanism of action of TYB on spermatozoa is still unknown, and various hypotheses have been put forward. Prolonged storage at 37°C may lead to increased capacitation (Scobey et al., 1996) . Changes in sperm membrane phospholipid/cholesterol ratio may also account for an increased number of spermatozoa undergoing the acrosome reaction (Biefeld et al., 1990) . Motility assessment with the Hamilton Thorn instrument showed that path velocity (average motile sperm velocity along the track) and progressive velocity (mean progressive motile sperm velocity) were significantly higher with TYB than with standard swim-up sperm preparation (Ragni et al., 1993) . It is interesting that, in our study, TYB significantly increased pregnancy rate in patients with unexplained infertility but not in those with male factor. These results further confirm those of Menge et al. (1992) . TYB may therefore have a positive effect on apparently normal spermatozoa by perhaps correcting an acrosome reaction defect.
These results are encouraging. Future studies are warranted in order to evaluate the effects of TYB on abnormal spermatozoa as well as on normal spermatozoa with possible defects that cannot be assessed during standard analysis. In particular, the impact of TYB on sperm function and its role in inducing the acrosome reaction should be further investigated.
